February 12, 2020

Change in the management team

Lund, Sweden, 17:00 PM CET, 12 February 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its management tea...
Read more
January 31, 2020

BONESUPPORT HOLDING AB signs an agreement on a working capital facility of SEK 60 million

Lund, Sweden, 12:00 pm CET, 31 January 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has sign...
Read more
January 30, 2020

Aprea Therapeutics Receives FDA Breakthrough Therapy Designation for APR-246 in Combination with Azacitidine for the Treatment of Myelodysplastic Syndromes (MDS) with a TP53 Mutation

BOSTON, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeuti...
Read more
January 30, 2020

Q4 incl. Full Year Report 2019

Strong fundamentals in place to fuel strategy for future growth Q4 2019 highlights Total net revenues of SEK 238.1 million (227.1), up 4.8 percent Zubsolv® US net r...
Read more
January 29, 2020

Promising results from human PK study assessing novel ketorolac formulations for treatment of pain

OX338 demonstrated improved bioavailability and tolerability compared to commercially available reference product Further work required to optimise product formulation ...
Read more
January 24, 2020

Oncopeptides will host a webcast on Monday, January 27th at 11.00 (CET)

STOCKHOLM — January 24, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that it will host a webcast at 11am (CET) on Monday, January 27th 2020 where CEO ...
Read more
January 22, 2020

TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CH...
Read more
January 22, 2020

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CH...
Read more
January 21, 2020

Targovax announces encouraging data in mesothelioma study combining ONCOS-102 and standard of care chemotherapy

Preliminary data show a numerical advantage in Progression Free Survival in ONCOS-102 treated patients Robust immune activation in the experimental group, with a positive as...
Read more
January 21, 2020

GenSight Biologics Reports its Cash Position as of December 31, 2019 and Provides Operational Update

Paris, France, January 21, 2020, 7.30 am CET – GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and develop...
Read more
Older news →